Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Fluid retention
ADR ID BADD_A01668
ADR Hierarchy
14      Metabolism and nutrition disorders
14.05      Electrolyte and fluid balance conditions
14.05.06      Total fluid volume increased
14.05.06.002      Fluid retention
20      Renal and urinary disorders
20.01      Renal disorders (excl nephropathies)
20.01.02      Renal disorders NEC
20.01.02.003      Fluid retention
Description Not Available
MedDRA Code 10016807
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Body fluid retention | Extracellular fluid increased | Fluid retention | Fluid retention in tissues | Free water clearance decreased | Idiopathic fluid retention | Interstitial fluid increased | Retention water | Tissue fluid increased | Water retention | Water retention in tissues | Water retention of
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01281Levonorgestrel--
BADD_D01285Levothyroxine0.000057%
BADD_D01295Linezolid--
BADD_D01296Liothyronine0.000847%
BADD_D01300Lisinopril--
BADD_D01311Lomitapide0.000021%
BADD_D01322Losartan0.000058%
BADD_D01336Macitentan0.040904%
BADD_D01365Medroxyprogesterone--
BADD_D01366Medroxyprogesterone acetate0.000238%
BADD_D01368Mefenamic acid--
BADD_D01371Megestrol--
BADD_D01372Megestrol acetate--
BADD_D01374Meloxicam0.000035%
BADD_D01401Metformin--
BADD_D01433Methylprednisolone0.000166%
BADD_D01434Methylprednisolone acetate--
BADD_D01435Methylprednisolone hemisuccinate--
BADD_D01436Methylprednisolone sodium succinate--
BADD_D01438Methyltestosterone--
BADD_D01442Metoclopramide--
BADD_D01443Metoclopramide hydrochloride--
BADD_D01455Micafungin--
BADD_D01473Minoxidil--
BADD_D01476Mirtazapine0.000336%
BADD_D01507Mycophenolate mofetil--
BADD_D01508Mycophenolic acid--
BADD_D01512Nadolol--
BADD_D01530Nandrolone decanoate--
BADD_D01533Naproxen--
The 5th Page    First    Pre   5 6 7 8 9    Next   Last    Total 10 Pages